Related Experiment Video
Updated: Apr 3, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Hypointense hepatocellular carcinomas on apparent diffusion coefficient mapping: Pathological features and metastatic
Yoshiyuki Mori1, Hideyuki Tamai1, Naoki Shingaki1
1Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Hypointense hepatocellular carcinomas (HCC) on apparent diffusion coefficient (ADC) maps indicate poor differentiation and portal invasion. This finding is a significant predictor of metastatic recurrence after surgery.
Area of Science:
- Hepatobiliary imaging
- Oncology
- Radiology
Background:
- Hepatocellular carcinoma (HCC) is a primary liver malignancy.
- Diffusion-weighted magnetic resonance imaging (DW-MRI) is a key diagnostic tool.
- Apparent diffusion coefficient (ADC) mapping provides insights into tissue microstructure.
Purpose of the Study:
- To evaluate pathological features of HCC with hypointense signal on ADC maps.
- To determine the association between ADC map signal intensity and metastatic recurrence post-hepatectomy.
Main Methods:
- 52 patients with HCC underwent DW-MRI before hepatectomy.
- HCC signal intensity on ADC maps was compared to surrounding liver.
- Tumors were categorized as hypointense or non-hypointense on ADC maps.
Main Results:
- Hypointense HCC showed significantly higher rates of poor histological differentiation and microscopic portal invasion.
- 3-year metastatic recurrence rates were 56% for hypointense HCC vs. 13% for non-hypointense HCC.
- ADC map hypointensity was the sole independent predictor of metastatic recurrence.
Conclusions:
- Hypointense HCC on ADC maps are pathologically distinct, exhibiting aggressive features.
- ADC map signal intensity is a valuable prognostic marker for HCC recurrence.
- This imaging characteristic aids in predicting patient outcomes after liver surgery.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024